Vasculitis: lessons learned

Here is an important editorial by Philip Seo in the "Current Opinion of Rheumatology."

Very important points in this editorial are that cychlophosphamide is the best current treatment for run-away vasculitis, that trials outside the US have provided important information about vasculitis disease, and that the phenotype (or body type) of the individual patient needs to be taken into consideration when treating vasculitis.

My opinion: It sounds like that rheumatology (treatment of such disease like vasculitis, arthritis, etc) is learning some valuable lessons in treating my disease and others in the same category.